Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery. The results of their study were published in a recent issue of the Annals of Surgery.
Recent PostsSaturday, January 14, 2017
The University of South Florida College of Engineering and the USF Health Morsani College of Medicine have established the Department of Medical Engineering, a unique transdisciplinary concept that will combine the related aspects of engineering and medicine while providing access to real-world health care environments for education and research. ..Read More ⇒Thursday, January 12, 2017
Florida-based Flight Level Engineering has become the first company to join the Customized Business Acceleration Program at the John Mica Engineering and Aerospace Innovation Complex (MicaPlex) at Embry-Riddle Research Park in Daytona Beach. ..Read More ⇒Thursday, January 12, 2017
According to a 2015 report by the NIH’s National Institute on Aging, in the last five years of life, total health care spending for people with dementia was more than a quarter of a million dollars per person, 57 percent more than the costs associated with death from other diseases, including cancer and heart disease. ..Read More ⇒Thursday, January 12, 2017
Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease. ..Read More ⇒Wednesday, January 11, 2017
Graft-versus-host-disease (GVHD) is the leading cause of non-relapse associated death in patients who receive stem cell transplants. In a new study published as the cover story in Science Translational Medicine, Moffitt Cancer Center researchers show that a novel treatment can effectively inhibit the development of GVHD in mice and maintain the infection- and tumor-fighting capabilities of the immune system. ..Read More ⇒
TagsDraper energy research photonics business aging Nanotheraputics Florida State University physics materials science BioFlorida Florida Trend ecology economy neuroscience Mayo Clinic Univeristy of South Florida children clean energy Florida Power & Light Embry-Riddle biotechnology AGTC AxoGen Max Planck sustainability FL Institute for Commercialization of Public Research University of North Florida University of Miami gender animals IHMC agriculture GrowFL University of West Florida Moffitt Cancer Center society/culture Florida International Univ. Florida Atlantic University Florida Gulf Coast Univ. medical education stem cell research policy bioscience health care marine aerospace Jackson Lab magnets University of Central Florida Florida Hospital Nova Southeastern Univ. Torrey Pines Institute biochemistry engineering ICFO University of Florida innovation Enterprise Florida technology sciences health biomedical Sanford-Burnham Scripps Research Institute commercialization HIV/AIDS conference / event FAMU Florida Institute of Technology accounting awards environment consumers VGTI astronomy green technology partnerships policy accreditation accolades robotics nanotechnology computer science Banyan Biomarkers grants cancer